Abstract
Background
Folate supplementation treatment is the first-line therapy in hyperhomocysteinaemia (HHcy). Up to 40% of HHcy patients do not benefit from folate therapy. Genetic and epigenetic factors of one-carbon metabolism (1-CM) might be identified as a predictor of folate supplementation treatment response. In the present study, we attempt to identify whether genetic and epigenetic factors might predict folate treatment response.
Methods
A total of 230 patients with HHcy were involved in this prospective cohort study. Differences between baseline concentrations and concentrations obtained at 90 days of treatment were calculated to evaluate the treatment response. General linear models and Pearson correlation was used to explore associations among single-nucleotide polymorphisms (SNPs), DNA methylation, and folate treatment response. Finally, mediation analysis was performed to investigate whether DNA methylation of MTRR mediates the association between SNPs and treatment response.
Results
MTHFD rs1950902 and MTRR rs162036, rs1801394 was associated with the folate treatment response (P = 0.000, 0.048, and 0.043, respectively). CBS and CBS_2 DNA methylation was significantly associated with folate treatment response (P = 0.0009 and < 0.001). DNA methylation of MTHFR, MTR, and MTRR was also significantly associated with folate treatment response (P < 0.001). DNA methylation of MTRR and MTRR_1 mediated 40.71% and 40.47% of the effect of rs1801394 on folate treatment response, respectively.
Conclusions
Our results indicated that the 1-CM gene SNPs and DNA methylation was associated with folate treatment response and can be further evaluated relationship between SNPs and DNA methylation in 1-CM with treatment response in a larger sample.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rosi J, Morais BA, Pecorino LS, Oliveira AR, Solla DJF, Teixeira MJ, et al. Hyperhomocysteinemia as a risk factor for intracranial Aneurysms: a case–control study. World Neurosurg. 2018;119:e272–e5.
Fu Y, Wang X, Kong W. Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets. Br J Pharmacol. 2018;175:1173–89.
Homocysteine Lowering Trialists C. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr. 2005;82:806–12.
Anderson JL, Jensen KR, Carlquist JF, Bair TL, Horne BD, Muhlestein JB. Effect of folic acid fortification of food on homocysteine-related mortality. Am J Med. 2004;116:158–64.
Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368:149–60.
Hannibal L, Blom HJ. Homocysteine and disease: causal associations or epiphenomenons? Mol Asp Med. 2017;53:36–42.
van Meurs JB, Pare G, Schwartz SM, Hazra A, Tanaka T, Vermeulen SH, et al. Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. Am J Clin Nutr. 2013;98:668–76.
Pastore A, De Angelis S, Casciani S, Ruggia R, Di Giovamberardino G, Noce A, et al. Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes. Clin Chem. 2006;52:145–8.
Whitfield JB. Genetic insights into cardiometabolic risk factors. Clin Biochem Rev. 2014;35:15–36.
Ladd-Acosta C, Fallin MD. The role of epigenetics in genetic and environmental epidemiology. Epigenomics. 2016;8:271–83.
Waddington CH. Canalization of development and genetic assimilation of acquired characters. Nature. 1959;183:1654–5.
Bird AP. CpG-rich islands and the function of DNA methylation. Nature. 1986;321:209–13.
Rakyan VK, Preis J, Morgan HD, Whitelaw E. The marks, mechanisms and memory of epigenetic states in mammals. Biochem J. 2001;356:1–10.
Wajed SA, Laird PW, DeMeester TR. DNA methylation: an alternative pathway to cancer. Ann Surg. 2001;234:10–20.
Kader F, Ghai M, Maharaj L. The effects of DNA methylation on human psychology. Behav Brain Res. 2018;346:47–65.
Ramos RB, Fabris V, Lecke SB, Maturana MA, Spritzer PM. Association between global leukocyte DNA methylation and cardiovascular risk in postmenopausal women. BMC Med Genet. 2016;17:71.
Stirzaker C, Zotenko E, Clark SJ. Genome-wide DNA methylation profiling in triple-negative breast cancer reveals epigenetic signatures with important clinical value. Mol Cell Oncol. 2016;3:e1038424.
Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA. 2002;99:5606–11.
Axume J, Smith SS, Pogribny IP, Moriarty DJ, Caudill MA. The MTHFR 677TT genotype and folate intake interact to lower global leukocyte DNA methylation in young Mexican American women. Nutr Res. 2007;27:1365–17.
Grant CD, Jafari N, Hou L, Li Y, Stewart JD, Zhang G, et al. A longitudinal study of DNA methylation as a potential mediator of age-related diabetes risk. Geroscience. 2017;39:475–89.
Baszczuk A, Kopczynski Z. Hyperhomocysteinemia in patients with cardiovascular disease. Postepy Hig Med Dosw. 2014;68:579–89.
Imai K, Keele L, Tingley D, Yamamoto T. Causal mediation analysis using R. New York, NY: Springer New York; 2010. p. 129–54.
Pizzolo F, Blom HJ, Choi SW, Girelli D, Guarini P, Martinelli N, et al. Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia. J Am Coll Nutr. 2011;30:11–8.
Dayon L, Guiraud SP, Corthesy J, Da Silva L, Migliavacca E, Tautvydaite D, et al. One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond. Alzheimers Res Ther. 2017;9:43.
Du B, Tian H, Tian D, Zhang C, Wang W, Wang L, et al. Genetic polymorphisms of key enzymes in folate metabolism affect the efficacy of folate therapy in patients with hyperhomocysteinaemia. Br J Nutr. 2018;119:887–95.
Wang L, Ke Q, Chen W, Wang J, Tan Y, Zhou Y, et al. Polymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese population. Clin Cancer Res. 2007;13:2526–32.
Li Y, Cheng J, Zhu WL, Dao JJ, Yan LY, Li MY, et al. Study of serum Hcy and polymorphisms of Hcy metabolic enzymes in 192 families affected by congenital heart disease. Beijing Da Xue Xue Bao Yi Xue Ban. 2005;37:75–80.
Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet. 1999;354:407–13.
Wei LH, Chao NX, Gao S, Yu YT, Shi L, Ma XB, et al. Homocysteine induces vascular inflammatory response via SMAD7 hypermethylation in human umbilical vein smooth muscle cells. Microvasc Res. 2018;120:8–12.
Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, et al. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis. 2008;29:356–62.
Basir A. Methionine synthase reductase-A66G and -C524T single nucleotide polymorphisms and prostate cancer: a case–control trial. Asian Pac J Cancer Prev. 2019;20:1445–51.
Zhang Z, He Y, Tu X, Huang S, Chen Z, Wang L, et al. Mapping of DNA hypermethylation and hypomethylation induced by folate deficiency in sporadic colorectal cancer and clinical implication analysis of hypermethylation pattern in CBS promoter. 2017;63:733–48.
Rothman JK. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43–6.
Anderson OS, Sant KE, Dolinoy DC. Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J Nutr Biochem. 2012;23:853–9.
Guerra S, Melen E, Sunyer J, Xu CJ, Lavi I, Benet M, et al. Genetic and epigenetic regulation of YKL-40 in childhood. J Allergy Clin Immunol. 2018;141:1105–14.
Keele L. Causal mediation analysis: warning! Assumptions ahead. Am J Eval. 2015;36:1098214015594689.
Acknowledgements
We appreciated all the members from the Fifth Affiliated Hospital of Zhengzhou University to achieve such results for their truly magnificent efforts. The Department of Science and Technology of Henan Province had no role in the design, analysis, or writing of this article.
Funding
Funding was provided by the Department of Science and Technology of Henan Province (no.132102310431).
Author information
Authors and Affiliations
Contributions
All authors reviewed and approved the final paper. DL had full access to the data and write the paper; QZ and XH: experiments conception and design; OG: data acquisition; CZ: data analysis and interpretation; WZ: study supervision.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Li, D., Zhao, Q., Huang, X. et al. Association of genetic and epigenetic variants in one-carbon metabolism gene with folate treatment response in hyperhomocysteinaemia. Eur J Clin Nutr 74, 1073–1083 (2020). https://doi.org/10.1038/s41430-020-0611-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-020-0611-x